author-photo

Lian Sheng Zhang

Lanzhou University

8

Papers

20

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Bendamustine treatment of Chinese patients with relapsed indolent non-Hodgkin lymphoma: a multicenter, open-label, single-arm, phase 3 study.

2021 Chinese Medical Journal
Show All
- Source
- Cite
- Save
Citations (0)
Dose tapering to withdrawal stage and long-term efficacy and safety of hetrombopag for the treatment of immune thrombocytopenia: results from an open-label extension study.

2021 Journal of Thrombosis and Haemostasis
Show All
- Source
- Cite
- Save
Citations (0)
Opportunities and Challenges for Gut Microbiota in Acute Leukemia.

2021 Frontiers in Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia.

2021 Journal of Hematology & Oncology
Show All
- Source
- Cite
- Save
Citations (5)
Risk stratification and outcomes of intracranial hemorrhage in patients with immune thrombocytopenia under 60 years of age.

2020 Platelets
Show All
- Source
- Cite
- Save
Citations (3)
Standardized fluorescence in situ hybridization testing based on an appropriate panel of probes more effectively identifies common cytogenetic abnormalities in myelodysplastic syndromes than conventional cytogenetic analysis: A multicenter prospective study of 2302 patients in China

2015 Leukemia Research
Show All
- Source
- Cite
- Save
Citations (12)
Dendritic cell immunotherapy:stumble and expects

2013
- Li-juan Li
- Lian Sheng Zhang
Show All
- Source
- Cite
- Save
Citations (0)
Plasmacytoid Dendritic Cells Derived from Chronic Myeloid Leukemia Induced by Low Dose Cytosine Arabinoside Combined with Flt-3L and TPO

2008 Blood
- Lijuan Li
- Lian Sheng Zhang
Show All
- Source
- Cite
- Save
Citations (0)